Diabetes 53:S165-S168, 2004
© 2004 by the American Diabetes Association, Inc.
Section IV: Non-Beta-Cell ATP-Sensitive K+ Channels |
Genetic Disruption of Kir6.2, the Pore-Forming Subunit of ATP-Sensitive K+ Channel, Predisposes to Catecholamine-Induced Ventricular Dysrhythmia
Xiao-Ke Liu1,
Satsuki Yamada1,
Garvan C. Kane1,
Alexey E. Alekseev1,
Denice M. Hodgson1,
Fearghas OCochlain1,
Arshad Jahangir1,
Takashi Miki2,
Susumu Seino2, and
Andre Terzic1
1 Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota
2 Division of Cellular and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
 |
ABSTRACT
|
|---|
Metabolic-sensing ATP-sensitive K+ channels (KATP channels) adjust membrane excitability to match cellular energetic demand. In the heart, KATP channel activity has been linked to homeostatic shortening of the action potential under stress, yet the requirement of channel function in securing cardiac electrical stability is only partially understood. Here, upon catecholamine challenge, disruption of KATP channels, by genetic deletion of the pore-forming Kir6.2 subunit, produced defective cardiac action potential shortening, predisposing the myocardium to early afterdepolarizations. This deficit in repolarization reserve, demonstrated in Kir6.2-knockout hearts, translated into a high risk for induction of triggered activity and ventricular dysrhythmia. Thus, intact KATP channel function is mandatory for adequate repolarization under sympathetic stress providing electrical tolerance against triggered arrhythmia.
Expressed at high density in the cardiac sarcolemma, ATP-sensitive K+ (KATP) channels are heteromultimers of the pore-forming Kir6.2 subunit with the regulatory sulfonylurea receptor (1). By virtue of a unique ability to decode signals of cellular energetic distress, KATP channels adjust membrane electrical activity in response to metabolic demand (2,3). Disturbances in KATP channel function, either through pharmacological blockade with sulfonylurea medication or through genetic mutation of channel proteins, have been linked to increased susceptibility for development and progression of cardiovascular conditions (48).
In particular, in hyperadrenergic states, ranging from physical exertion to decompensated heart failure, cardiac KATP channels have been implicated in the maintenance of cellular well-being and stress adaptation (911). Specifically, under catecholamine surge, proper KATP channel activity is required for the coordinated adjustment of membrane-dependent cellular functions, including adequate calcium handling and sustained contractility (9,10). Although KATP channel opening has been associated with homeostatic shortening of the cardiac action potential under increased metabolic demand (6,9), the precise role of channel function in support of cardiac electrical stability is only partially understood. Thus, this study was designed to address the contribution of KATP channels in membrane electrical tolerance in the heart under adrenergic stress.
To this end, the electrical consequences of adrenergic stress were tested in hearts lacking the pore-forming subunit of KATP channels, through genetic disruption of Kir6.2, and compared with the wild type. In KATP channel knockout hearts, sympathomimetic challenge unmasked an inadequate repolarization reserve predisposing to abnormal action potentials with afterdepolarizations and inducing ventricular dysrhythmia. Hence, KATP channels are required for electrical adaptation that protects against triggered arrhythmia within the adrenergically stressed myocardium.
 |
RESEARCH DESIGN AND METHODS
|
|---|
Kir6.2-knockout mice.
Mice deficient in KATP channels were generated by targeted disruption of the KCNJ11 gene, which encodes the pore-forming Kir6.2 subunit of the channel complex (12). Kir6.2-knockout mice were backcrossed for five generations into a C57BL/6 background. This investigation was approved by the Mayo Clinic Institutional Animal Care and Use Committee.
In situ aortic cannulation and Langendorff perfusion.
Mice were anesthetized with intraperitoneal injection of 2,2,2-tribromoethanol (0.375 mg/g body wt; Sigma), intubated, and ventilated, and the aortic root was cannulated in situ (10). Perfusion was sustained ex vivo on a Langendorff system, at 90 cm H2O with 37°C-prewarmed and 100% O2-bubbled Tyrode solution (in mmol/l: NaCl 137, KCl 5.4, CaCl2 2, MgCl2 1, HEPES 10, and glucose 10, pH 7.4 with NaOH). After a 10-min equilibration, KCl was reduced to 2.7 mmol/l and MgCl2 to 0.5 mmol/l, with the atrioventricular node cauterized to allow ventricular pacing (13). Coronary flow was monitored with a T106 blood flow meter (Transonic Systems).
Electrogram and monophasic action potential recordings.
Orthogonal electrogram signals were simultaneously recorded using four silver-silver chloride electrodes surrounding the perfused heart in a simulated "Einthoven" configuration, and signals were amplified by an electrocardiographic amplifier (Gould Electronics). A catheter (NuMed) was placed in the left ventricular endocardium to pace the heart at twice diastolic threshold intensity with 2-ms pulse width and 100-ms cycle length using a pulse generator (A310 Accupulser; World Precision Instruments). Monophasic action potentials were continuously recorded from the left ventricle by a probe (EP Technologies) positioned on the epicardial surface, and amplified signals (IsoDam; World Precision Instruments) were acquired at 11.8 kHz and stored for off-line digital analysis (9).
Whole-cell patch clamp recording from isolated cardiomyocytes.
Cardiomyocytes were enzymatically dissociated from the ventricular myocardium (10). Action potentials were recorded at 30 ± 1°C from current-clamped isolated cells paced at 1 Hz, and were superfused with Tyrode solution (pH 7.2 adjusted with KOH) using the whole-cell patch clamp technique with 510 mol/l pipettes containing (in mmol/l) KCl 120, MgCl2 1, Na2ATP 5, HEPES 10, EGTA 0.5, and CaCl2 0.01 (14).
Statistics.
Comparisons were made using the Students t test. A significance level of 0.05 was preselected. Data are reported as means ± SE.
 |
RESULTS AND DISCUSSION
|
|---|
Whereas at baseline the action potentials were similar, the metabolic challenge of adrenergic stimulation induced distinct outcomes depending on the presence of functional KATP channels, with significant shortening of the action potential duration observed in wild-type hearts but not in age- and sex-matched counterparts lacking the Kir6.2 pore-forming channel subunit (Kir6.2-KO) (Fig. 1A and B). After a 10-min perfusion with the sympathomimetic isoproterenol (1 µmol/l), monophasic action potential duration at 90% repolarization (APD90) shortened from 82 ± 2 to 74 ± 2 ms in wild-type hearts (P < 0.01, n = 6; Fig. 1A). In contrast, APD90 remained at 79 ± 3 and 80 ± 3 ms before and following isoproterenol treatment, respectively, in Kir6.2-KO hearts (n = 6) (Fig. 1B). This deficit in repolarization led to distorted action potential profiles with characteristic phase 3 early afterdepolarizations manifested as distinct humps in hearts lacking functional KATP channels (Fig. 1B and C). In all Kir6.2-KO hearts (n = 8), adrenergic challenge induced early afterdepolarizations, which occurred in 97 ± 2% of the action potentials examined (Fig. 1D). This is in contrast to the action potential profile of the wild type (n = 6) that maintained a smooth repolarization contour following isoproterenol challenge (Fig. 1A) without significant afterdepolarizations (1 ± 1%; P < 0.01 vs. Kir6.2-KO) (Fig. 1D).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 1. Isoproterenol challenge induced action potential shortening (APD90) in wild-type (WT) (A) but not Kir6.2-KO (B) hearts, which developed early afterdepolarizations (EAD) (C). D: Incidence of EAD in the initial 50 action potentials after 5 min of isoproterenol infusion.
|
|
Abnormal electrical response of Kir6.2-KO hearts under adrenergic challenge was not associated with an isoproterenol-induced deficit in coronary perfusion (Fig. 2A). In fact, abnormal electrical activity during repolarization observed at the whole-heart level was reproduced at the single-cell level using action potential recording in isoproterenol-stressed current-clamped Kir6.2-KO cardiomyocytes (Fig. 2B).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2. A: Similar coronary flow in the absence and presence of isoproterenol (1 µmol/l) in wild-type (WT) and Kir6.2-KO hearts. B: Isoproterenol-induced abnormal repolarization with early afterdepolarization in an isolated current-clamped Kir6.2-KO cardiomyocyte.
|
|
Afterdepolarizations in isoproterenol-challenged Kir6.2-KO hearts translated into increased electrical vulnerability (Fig. 3). In the absence of functional KATP channels, afterdepolarizations induced triggered activity, disrupting regular rhythm and manifesting as premature ventricular complexes on the electrogram (Fig. 3A). On average, isoproterenol-induced afterdepolarizations complicated by triggered activity were observed in six of eight Kir6.2-KO (75%) compared with one of six wild-type (16%) hearts, translating into a 16-fold higher risk (P < 0.05) of developing premature ventricular complexes (Fig. 3B). Hence, absence of KATP channels produces a deficit in the repolarization reserve leading to a pronounced susceptibility of Kir6.2-KO hearts to isoproterenol-induced ventricular dysrhythmia. Thus, sarcolemmal KATP channels provide for membrane electrical stability that reduces the risk for arrhythmia under hyperadrenergic conditions.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3. A: Kir6.2-KO hearts with early afterdepolarizations (EAD) demonstrated triggered activity on monophasic action potentials (MAP) and premature ventricular complexes (PVC) on electrograms (EG). For comparison, an EG is shown from wild-type hearts that are not prone to EAD-triggered activity/PVC. B: Incidence of triggered activity with accompanying PVC in the initial 50 action potentials following 5 min of isoproterenol infusion.
|
|
Imposed catecholamine stress is a well-established precipitator of triggered activity and arrhythmia (15,16). Analogous to hearts with genetic and/or environmental compromise of repolarizing currents, as observed in congenital or acquired long QT syndrome (17), here isoproterenol challenge was proarrhythmic in the KATP channeldeficient myocardium provoking afterdepolarizations and triggered activity. This is in line with pharmacological studies that demonstrate that KATP channel activation with potassium channel openers preventswhereas channel blockade with sulfonylurea drugs enhancesafterdepolarizations and triggered activity (1820). In fact, in a recent randomized clinical trial in patients with type 2 diabetes, the sulfonylurea glyburide, but not the alternative oral hypoglycemic agent metformin, caused an increase in QT prolongation with QT dispersion on the electrocardiogram (21). Moreover, mutations in the cardiac sulfonylurea receptor inducing deficits in KATP channel function have been identified in patients with cardiomyopathy and ventricular arrhythmia (8).
Suppression of KATP channel activity, whether by genetic deletion of channel subunits or through use of channel antagonists, predisposes to inadequate calcium handling and intracellular calcium overload (5,9). In turn, excessive cytosolic calcium acts as a trigger for early depolarizations (22,23). Conversely, in the intact heart, where KATP channel opening is promoted by ß-adrenergicmediated phosphorylation of channel proteins (24,25) or subsarcolemmal ATP depletion (26), shortening of cardiac action potentials would balance catecholamine-induced increase in calcium influx protecting against triggered arrhythmia.
In summary, the present study underscores the homeostatic requirement for functional KATP channels in the adaptation of cardiac repolarization under adrenergic stress. In this regard, a deficit in KATP channel function is here identified as a previously unrecognized risk factor for the development of catecholamine-induced afterdepolarizations and triggered arrhythmia.
 |
ACKNOWLEDGMENTS
|
|---|
Supported by the National Institutes of Health (HL64822, GM08685, HL07111, and AG21201), American Heart Association, Miami Heart Research Institute, Marriott Foundation, Mayo Foundation Clinician-Investigator Program, Japan Heart Foundation, Mayo-Dubai Healthcare City Research Project, and Japanese Ministry of Education, Science, Sports, Culture and Technology. A.T. is an Established Investigator of the American Heart Association.
 |
FOOTNOTES
|
|---|
This article is based on a presentation at a symposium. The symposium and the publication of this article were made possible by an unrestricted educational grant from Servier.
Address correspondence and reprint requests to Andre Terzic, MD, PhD, Guggenheim 7, Mayo Clinic, Rochester, MN 55905. E-mail: terzic.andre{at}mayo.edu
Received for publication March 12, 2004
and accepted in revised form May 18, 2004
Abbreviations:
APD90, action potential duration at 90% repolarization; KATP channel, ATP-sensitive K+ channel; Kir6.2-KO, Kir6.2 knockout
 |
REFERENCES
|
|---|
- Inagaki N, Gonoi T, Clement JP, Wang CZ, Aguilar-Bryan L, Bryan J, Seino S: A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.
Neuron16
:1011
1017,1996[Medline]
- Carrasco AJ, Dzeja PP, Alekseev AE, Pucar D, Zingman LV, Abraham MR, Hodgson D, Bienengraeber M, Puceat M, Janssen E, Wieringa B, Terzic A: Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels.
Proc Natl Acad Sci U S A98
:7623
7628,2001[Abstract/Free Full Text]
- Abraham MR, Selivanov VA, Hodgson DM, Pucar D, Zingman LV, Wieringa B, Dzeja PP, Alekseev AE, Terzic A: Coupling of cell energetics with membrane metabolic sensing: integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knockout.
J Biol Chem277
:24427
24434,2002[Abstract/Free Full Text]
- Meinert CL, Knatterud GL, Prout TE, Klimt C: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: mortality results.
Diabetes19
:789
830,1970
- Brady PA, Terzic A: The sulfonylurea controversy: more questions from the heart.
J Am Coll Cardiol31
:950
956,1998[Abstract/Free Full Text]
- Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Seino S, Marban E, Nakaya H: Role of sarcolemmal KATP channels in cardioprotection against ischemia/reperfusion injury in mice.
J Clin Invest109
:509
516,2002[Medline]
- Gumina RJ, Pucar D, Bast P, Hodgson DM, Kurtz CE, Dzeja PP, Miki T, Seino S, Terzic A: Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics.
Am J Physiol284
:H2106
H2113,2003
- Bienengraeber M, Olson TM, Selivanov VA, Kathmann EC, OCoclain F, Gao F, Karger AB, Ballew JD, Hodgson DM, Zingman LV, Pang Y-P, Alekseev AE, Terzic A: ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating.
Nat Genet36
:382
387,2004[Medline]
- Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE, Terzic A: Kir6.2 is required for adaptation to stress.
Proc Natl Acad Sci U S A99
:13278
13283,2002[Abstract/Free Full Text]
- Hodgson DM, Zingman LV, Kane GC, Perez-Terzic C, Bienengraeber M, Ozcan C, Gumina RJ, Pucar D, OCoclain F, Mann DL, Alekseev AE, Terzic A: Cellular remodeling in heart failure disrupts KATP channel-dependent stress tolerance.
EMBO J22
:1732
1742,2003[Medline]
- Kane GC, Behfar A, Yamada S, Perez-Terzic C, OCochlain F, Reyes S, Dzeja PP, Miki T, Seino S, Terzic A: ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits.
Diabetes53 (Suppl. 3)
:S169
S175,2004
- Miki T, Nagashima K, Tashiro F, Kotake K, Yoshitomi H, Tamamoto A, Gonoi T, Iwanaga T, Miyazaki J, Seino S: Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice.
Proc Natl Acad Sci U S A95
:10402
10406,1998[Abstract/Free Full Text]
- Liu XK, Wang W, Ebert SN, Franz MR, Katchman A, Woosley RL: Female gender is a risk factor for torsades de pointes in an in vitro animal model.
J Cardiovasc Pharmacol34
:287
294,1999[Medline]
- Chen YJ, Chen SA, Chen YC, Yeh HI, Chang MS, Lin CI: Electrophysiology of single cardiomyocytes isolated from rabbit pulmonary veins: implication in initiation of focal atrial fibrillation.
Basic Res Cardiol97
:26
34,2002[Medline]
- Zeng J, Rudy Y: Early afterdepolarizations in cardiac myocytes.
Biophys J68
:949
964,1995[Abstract/Free Full Text]
- Volders PG, KulcSar A, Vos MA, Sipido KR, Wellens HJ, Lazzara R, Szabo B: Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes.
Cardiovasc Res34
:348
359,1997[Abstract/Free Full Text]
- Anderson ME, Al-Khatib SM, Roden DM, Califf RM: Cardiac repolarization.
Am Heart J144
:769
781,2002[Medline]
- Antzelevitch C, Di Diego JM: Role of K+ channel activators in cardiac electrophysiology and arrhythmias.
Circulation85
:1627
1629,1992[Free Full Text]
- Shimizu W, Antzelevitch C: Effects of a K+ channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Circulation102
:706
712,2000[Abstract/Free Full Text]
- Pasnani JS, Ferrier GR: Differential effects of glyburide on premature beats and ventricular tachycardia in an isolated tissue model of ischemia and reperfusion.
J Pharmacol Exp Ther262
:1076
1084,1992[Abstract/Free Full Text]
- Najeed SA, Khan IA, Molnar J, Somberg JC: Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect.
Am J Cardiol90
:1103
1106,2002[Medline]
- Choi BR, Burton F, Salama G: Cytosolic Ca2+ triggers early afterdepolarizations and torsade de pointes in rabbit hearts with type 2 long QT syndrome.
J Physiol543
:615
631,2002[Abstract/Free Full Text]
- Volders PG, Vos MA, Szabo B, Sipido KR, de Groot SH, Gorgels AP, Wellens HJ, Lazzara R: Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes.
Cardiovasc Res46
:376
392,2000[Free Full Text]
- Beguin P, Nagashima K, Nishimura M, Gonoi T, Seino S: PKA-mediated phosphorylation of the human KATP channel.
EMBO J18
:4722
4732,1999[Medline]
- Lin YF, Jan YN, Jan LY: Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells.
EMBO J19
:942
955,2000[Medline]
- Schackow TE, Ten Eick RE: Enhancement of ATP-sensitive potassium current in cat ventricular myocytes by ß-adrenoreceptor stimulation.
J Physiol474
:131
145,1994[Abstract/Free Full Text]

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. V. Zingman, A. E. Alekseev, D. M. Hodgson-Zingman, and A. Terzic
ATP-sensitive potassium channels: metabolic sensing and cardioprotection
J Appl Physiol,
November 1, 2007;
103(5):
1888 - 1893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Gumina, D. F. O'Cochlain, C. E. Kurtz, P. Bast, D. Pucar, P. Mishra, T. Miki, S. Seino, S. Macura, and A. Terzic
KATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart
Am J Physiol Heart Circ Physiol,
April 1, 2007;
292(4):
H1706 - H1713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yamada, G. C. Kane, A. Behfar, X.-K. Liu, R. B. Dyer, R. S. Faustino, T. Miki, S. Seino, and A. Terzic
Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant
J. Physiol.,
December 15, 2006;
577(3):
1053 - 1065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Lu, D. Ye, X. Wang, J. M. Seubert, J. P. Graves, J. A. Bradbury, D. C. Zeldin, and H.-C. Lee
Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms
J. Physiol.,
September 1, 2006;
575(2):
627 - 644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Kane, A. Behfar, R. B. Dyer, D. F. O'Cochlain, X.-K. Liu, D. M. Hodgson, S. Reyes, T. Miki, S. Seino, and A. Terzic
KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension
Hum. Mol. Genet.,
August 1, 2006;
15(15):
2285 - 2297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Tong, L. M. Porter, G. Liu, P. Dhar-Chowdhury, S. Srivastava, D. J. Pountney, H. Yoshida, M. Artman, G. I. Fishman, C. Yu, et al.
Consequences of cardiac myocyte-specific ablation of KATP channels in transgenic mice expressing dominant negative Kir6 subunits
Am J Physiol Heart Circ Physiol,
August 1, 2006;
291(2):
H543 - H551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Cui, L. Li, X. Wang, Y. Shi, W. Shi, and C. Jiang
Elimination of allosteric modulation of myocardial KATP channels by ATP and protons in two Kir6.2 polymorphisms found in sudden cardiac death
Physiol Genomics,
March 13, 2006;
25(1):
105 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|
|